During the past decade, Laura and Isaac Perlmutter Cancer Center at NYU Langone conducted 262 clinical trials. In the 10-year time frame, 262 clinical trials started and 191 clinical trials were completed, i.e. on average, 72.9% percent of trials that started reached the finish line to date. In the past 5 years, 102 clinical trials started and 99 clinical trials were completed. i.e. 97.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Laura and Isaac Perlmutter Cancer Center at NYU Langone" #1 sponsor was "National Cancer Institute (NCI)" with 148 trials, followed by "Children's Oncology Group" with 81 trials sponsored, "NYU Langone Health" with 75 trials sponsored, "Eastern Cooperative Oncology Group" with 23 trials sponsored and "SWOG Cancer Research Network" with 23 trials sponsored. Other sponsors include 270 different institutions and companies that sponsored additional 128 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Laura and Isaac Perlmutter Cancer Center at NYU Langone" #1 collaborator was "National Cancer Institute (NCI)" with 233 trials as a collaborator, "NRG Oncology" with 26 trials as a collaborator, "Merck Sharp & Dohme LLC" with 12 trials as a collaborator, "Cancer and Leukemia Group B" with 11 trials as a collaborator and "SWOG Cancer Research Network" with 11 trials as a collaborator. Other collaborators include 183 different institutions and companies that were collaborators in the rest 106 trials.

According to Clinical.Site data, the most researched conditions in "Laura and Isaac Perlmutter Cancer Center at NYU Langone" are "Breast Cancer" (34 trials), "Ovarian Cancer" (25 trials), "Colorectal Cancer" (22 trials), "Leukemia" (22 trials) and "Lymphoma" (21 trials). Many other conditions were trialed in "Laura and Isaac Perlmutter Cancer Center at NYU Langone" in a lesser frequency.

Most popular intervention types in "Laura and Isaac Perlmutter Cancer Center at NYU Langone" are "Drug" (504 trials), "Other" (185 trials), "Biological" (179 trials), "Procedure" (131 trials) and "Radiation" (109 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (98 trials), "Quality-of-Life Assessment" (55 trials), "Carboplatin" (48 trials), "Cyclophosphamide" (41 trials) and "Questionnaire Administration" (39 trials). Other intervention names were less common.

The vast majority of trials in "Laura and Isaac Perlmutter Cancer Center at NYU Langone" are 507 trials for "All" genders, 88 trials for "Female" genders and 26 trials for "Male" genders.

Currently, there are NaN active trials in "Laura and Isaac Perlmutter Cancer Center at NYU Langone". undefined are not yet recruiting, 103 are recruiting, 150 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 294 completed trials in Laura and Isaac Perlmutter Cancer Center at NYU Langone, 6 suspended trials, and 51 terminated clinical trials to date.

Out of the total trials that were conducted in Laura and Isaac Perlmutter Cancer Center at NYU Langone, 126 "Phase 1" clinical trials were conducted, 295 "Phase 2" clinical trials and 210 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 25 trials that are defined as “Not Applicable".